Dmitry Balyasny’s Pulmonx LUNG Stock Holding History

Dmitry Balyasny’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-44,672	Closed	-$414K	–	2888
2024 Q1	$414K	Buy	+44,672	New	+$524K	﹤0.01%	2126
2022 Q1	–	Sell	-221,186	Closed	-$7.09M	–	2683
2021 Q4	$7.09M	Buy	+221,186	New	+$8.08M	0.02%	736

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dmitry Balyasny's LUNG Position: Q2 2024 in Review

Dmitry Balyasny sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 44,672 shares — an estimated $414K sold.

Dmitry Balyasny first reported a position in LUNG in Q4 2021 and held it in 2 quarters. The position peaked at $7.09M in Q4 2021. 112 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

Dmitry Balyasny reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
Dmitry Balyasny sold 44,672 Pulmonx shares in Q2 2024, an estimated $414K.
Dmitry Balyasny first reported a position in Pulmonx in Q4 2021 and held it in 2 quarters.
Dmitry Balyasny's Pulmonx position peaked at $7.09M in Q4 2021.
112 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.